SHREE OSWAL SEEDS AND CHEMICALS
|
SHREE OSWAL SEEDS AND CHEMICALS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.39 | -0.45 | 3.74 | 3.57 | 2.39 |
| CEPS(Rs) | 0.44 | -0.40 | 0.67 | 0.64 | 0.43 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 4.78 | 4.40 | 29.10 | 25.36 | 21.81 |
| Tax Rate(%) | 30.86 | 22.64 | 27.73 | 28.22 | 27.85 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 3.89 | 0.37 | 4.37 | 4.36 | 4.76 |
| EBIT Margin(%) | 3.81 | 0.22 | 4.26 | 4.24 | 4.65 |
| Pre Tax Margin(%) | 2.08 | -2.00 | 2.90 | 3.15 | 3.14 |
| PAT Margin (%) | 1.44 | -1.55 | 2.10 | 2.26 | 2.26 |
| Cash Profit Margin (%) | 1.64 | -1.35 | 2.25 | 2.42 | 2.45 |
| Performance Ratios | |||||
| ROA(%) | 3.11 | -3.29 | 4.56 | 5.12 | 4.59 |
| ROE(%) | 8.41 | -9.84 | 13.75 | 15.12 | 11.62 |
| ROCE(%) | 9.88 | 0.63 | 14.01 | 13.02 | 11.01 |
| Asset Turnover(x) | 2.17 | 2.13 | 2.18 | 2.26 | 2.03 |
| Sales/Fixed Asset(x) | 26.70 | 35.01 | 44.90 | 44.36 | 34.98 |
| Working Capital/Sales(x) | 7.39 | 9.16 | 6.77 | 6.20 | 4.76 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 |
| Receivable days | 22.27 | 17.50 | 18.47 | 19.28 | 20.96 |
| Inventory Days | 109.99 | 125.98 | 128.52 | 124.26 | 131.23 |
| Payable days | 5.72 | 3.98 | 4.34 | 3.88 | 3.04 |
| Valuation Parameters | |||||
| PER(x) | 30.17 | - | 14.46 | 3.20 | 12.88 |
| PCE(x) | 26.45 | -73.10 | 80.63 | 14.92 | 11.90 |
| Price/Book(x) | 2.43 | 6.62 | 11.16 | 2.25 | 1.41 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.60 | 1.22 | 1.95 | 0.53 | 0.55 |
| EV/Core EBITDA(x) | 15.01 | 293.97 | 44.13 | 11.99 | 11.46 |
| EV/EBIT(x) | 15.80 | 551.70 | 45.78 | 12.44 | 11.92 |
| EV/CE(x) | 1.73 | 3.14 | 6.22 | 1.06 | 0.96 |
| M Cap / Sales | 0.43 | 0.99 | 1.82 | 0.36 | 0.29 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -8.59 | -1.21 | 13.23 | 49.19 | 38.02 |
| Core EBITDA Growth(%) | 787.52 | -90.76 | 13.75 | 35.69 | 9.76 |
| EBIT Growth(%) | 1,481.73 | -94.89 | 13.84 | 35.97 | 12.23 |
| PAT Growth(%) | 184.81 | -172.92 | 4.98 | 48.89 | 19.85 |
| EPS Growth(%) | 184.81 | -112.15 | 4.98 | 48.89 | 19.85 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.96 | 1.59 | 0.92 | 1.08 | 1.30 |
| Current Ratio(x) | 1.55 | 1.35 | 1.48 | 1.51 | 1.63 |
| Quick Ratio(x) | 0.47 | 0.36 | 0.25 | 0.34 | 0.24 |
| Interest Cover(x) | 2.19 | 0.10 | 3.13 | 3.89 | 3.08 |
| Total Debt/Mcap(x) | 0.39 | 0.24 | 0.08 | 0.48 | 0.92 |
Compare Financial Ratios of peers of SHREE OSWAL SEEDS AND CHEMICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE OSWAL SEEDS AND CHEMICALS | ₹124.5 Cr | -2.5% | -8% | -39.2% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,193.9 Cr | 0.3% | -2.3% | -22.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,962.3 Cr | -2% | -3.5% | -2.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,964.7 Cr | 3.1% | 2.5% | -24.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,017.0 Cr | -8.2% | -20.6% | -40.5% | Stock Analytics | |
| INDO US BIOTECH | ₹256.8 Cr | -3% | -1.4% | -58.7% | Stock Analytics | |
SHREE OSWAL SEEDS AND CHEMICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE OSWAL SEEDS AND CHEMICALS | -2.5% |
-8% |
-39.2% |
| SENSEX | -0.6% |
1.7% |
4.6% |
You may also like the below Video Courses
